1. Home
  2. NVNO

NVNO

enVVeno Medical Corporation

Logo enVVeno Medical Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 3:59pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Founded: 1987 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 72.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 131.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.91 EPS Growth: N/A
52 Week Low/High: $2.51 - $6.97 Next Earning Date: 04-29-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: